CytomX Therapeutics Inc. (CTMX)

9.19
0.09 0.97
NASDAQ : Health Technology
Prev Close 9.28
Open 9.32
Day Low/High 9.07 / 9.58
52 Wk Low/High 8.07 / 19.75
Volume 97.25K
Avg Volume 302.40K
Exchange NASDAQ
Shares Outstanding 45.41M
Market Cap 420.94M
EPS -2.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CytomX Therapeutics Shares Cross Below Book Value

CytomX Therapeutics Shares Cross Below Book Value

In trading on Friday, shares of CytomX Therapeutics Inc crossed below their last reported book value — defined as common shareholder equity per share — of $9.00, changing hands as low as $8.98 per share. CytomX Therapeutics Inc shares are currently trading off about 1.3% on the day.

CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update

CytomX Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update

-Company to Host a Conference Call Today, August 7, 2019, at 5:00 p.m. ET / 2:00 p.m. PT-

CytomX Therapeutics To Present At The 2019 Wedbush PacGrow Healthcare Conference

CytomX Therapeutics To Present At The 2019 Wedbush PacGrow Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug.

CytomX Therapeutics To Announce Second Quarter 2019 Financial Results

CytomX Therapeutics To Announce Second Quarter 2019 Financial Results

-Teleconference Scheduled for August 7, 2019, at 5:00 p.m. ET-

First Week Of CTMX February 2020 Options Trading

First Week Of CTMX February 2020 Options Trading

Investors in CytomX Therapeutics Inc saw new options begin trading this week, for the February 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

10 Speculative Stock Plays in the Biotech Sector

10 Speculative Stock Plays in the Biotech Sector

For investors interested in biotech, there's a lot to choose from, with options ranging from startups with potentially blockbuster new treatments to companies those that have been around the block a few times.

CytomX Therapeutics Enters Oversold Territory (CTMX)

CytomX Therapeutics Enters Oversold Territory (CTMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of November 15th Options Trading For CytomX Therapeutics (CTMX)

First Week Of November 15th Options Trading For CytomX Therapeutics (CTMX)

Investors in CytomX Therapeutics Inc saw new options become available this week, for the November 15th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

CytomX Therapeutics Becomes Oversold (CTMX)

CytomX Therapeutics Becomes Oversold (CTMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of May 2019 Options Trading For CytomX Therapeutics (CTMX)

First Week Of May 2019 Options Trading For CytomX Therapeutics (CTMX)

Investors in CytomX Therapeutics Inc saw new options begin trading this week, for the May 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 213 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

CytomX Therapeutics Becomes Oversold (CTMX)

CytomX Therapeutics Becomes Oversold (CTMX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Relative Strength Alert For CytomX Therapeutics

Relative Strength Alert For CytomX Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CTMX Makes Notable Cross Below Critical Moving Average

CTMX Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of CytomX Therapeutics Inc crossed below their 200 day moving average of $25.03, changing hands as low as $24.79 per share. CytomX Therapeutics Inc shares are currently trading off about 3% on the day.

CTMX Crosses Above Key Moving Average Level

CTMX Crosses Above Key Moving Average Level

In trading on Tuesday, shares of CytomX Therapeutics Inc crossed above their 200 day moving average of $24.50, changing hands as high as $24.82 per share. CytomX Therapeutics Inc shares are currently trading up about 4.5% on the day.

First Week Of February 2019 Options Trading For CytomX Therapeutics (CTMX)

First Week Of February 2019 Options Trading For CytomX Therapeutics (CTMX)

Investors in CytomX Therapeutics Inc saw new options become available this week, for the February 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Advice for When the Trading's Too Easy

Advice for When the Trading's Too Easy

Buying right now feels like chasing.

CytomX Therapeutics Breaks Below 200-Day Moving Average - Notable For CTMX

CytomX Therapeutics Breaks Below 200-Day Moving Average - Notable For CTMX

In trading on Monday, shares of CytomX Therapeutics Inc crossed below their 200 day moving average of $23.65, changing hands as low as $20.82 per share. CytomX Therapeutics Inc shares are currently trading down about 17.4% on the day.

Relative Strength Alert For CytomX Therapeutics

Relative Strength Alert For CytomX Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

When the Stock Is the Only Option

When the Stock Is the Only Option

Options spreads aren't tradable with some small biotechs, making shares the only way to play.

First Week of November 16th Options Trading For CytomX Therapeutics (CTMX)

First Week of November 16th Options Trading For CytomX Therapeutics (CTMX)

Investors in CytomX Therapeutics Inc saw new options become available this week, for the November 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

CytomX Therapeutics Announces Full-Year 2017 Financial Results And Provides Operational Update

CytomX Therapeutics Announces Full-Year 2017 Financial Results And Provides Operational Update

Teleconference Scheduled for Today, March 7, 2018, at 5:00 p.m. ET

CytomX Therapeutics To Announce Full-Year 2017 Financial Results And Host Operational Update Webcast Conference Call

CytomX Therapeutics To Announce Full-Year 2017 Financial Results And Host Operational Update Webcast Conference Call

Teleconference Scheduled for March 7, 2018, at 5:00 p.m. ET

Short Interest Increases 36.2% For CTMX

Short Interest Increases 36.2% For CTMX

The most recent short interest data has been released for the 12/29/2017 settlement date, which shows a 305,296 share increase in total short interest for CytomX Therapeutics Inc , to 1,147,408, an increase of 36.25% since 12/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting CTMX Put And Call Options For August 17th

Interesting CTMX Put And Call Options For August 17th

Investors in CytomX Therapeutics Inc saw new options begin trading this week, for the August 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 221 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: D (Sell)